Clinical trial
Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration
NCT01467271 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration
- Lead sponsor
- Guerbet
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- June 30, 2017
- Enrollment
- 540 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.